Liujia He

1.1k total citations
11 papers, 688 citations indexed

About

Liujia He is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Liujia He has authored 11 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Liujia He's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer-related gene regulation (4 papers). Liujia He is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer-related gene regulation (4 papers). Liujia He collaborates with scholars based in China. Liujia He's co-authors include Jiangfeng Li, Liping Xie, Xin Xu, Xiangyi Zheng, Haiyun Xie, Yufan Ying, Xiao Wang, Huaqing Yan, Mingjie Xu and Ben Liu and has published in prestigious journals such as Molecular Cancer, Oncotarget and Cell Cycle.

In The Last Decade

Liujia He

11 papers receiving 685 citations

Peers

Liujia He
Serena Di Cecilia United States
Biao Que China
Liujia He
Citations per year, relative to Liujia He Liujia He (= 1×) peers Mingqing Wu

Countries citing papers authored by Liujia He

Since Specialization
Citations

This map shows the geographic impact of Liujia He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liujia He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liujia He more than expected).

Fields of papers citing papers by Liujia He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liujia He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liujia He. The network helps show where Liujia He may publish in the future.

Co-authorship network of co-authors of Liujia He

This figure shows the co-authorship network connecting the top 25 collaborators of Liujia He. A scholar is included among the top collaborators of Liujia He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liujia He. Liujia He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ma, Xueyou, Yufan Ying, Haiyun Xie, et al.. (2021). circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis. Cell Death Discovery. 7(1). 365–365. 20 indexed citations
2.
He, Liujia, Yufan Ying, Haiyun Xie, et al.. (2021). MicroRNA‐501‐3p inhibits the proliferation of kidney cancer cells by targeting WTAP. Cancer Medicine. 10(20). 7222–7232. 24 indexed citations
3.
Wang, Weiyu, Yufan Ying, Haiyun Xie, et al.. (2021). miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis. Cell Cycle. 20(13). 1242–1252. 23 indexed citations
4.
Xie, Haiyun, Jiangfeng Li, Yufan Ying, et al.. (2020). METTL3/YTHDF2 m 6 A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer. Journal of Cellular and Molecular Medicine. 24(7). 4092–4104. 114 indexed citations
5.
Li, Jiangfeng, Haiyun Xie, Yufan Ying, et al.. (2020). YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Molecular Cancer. 19(1). 152–152. 227 indexed citations
6.
Ying, Yufan, Jiangfeng Li, Haiyun Xie, et al.. (2020). CCND1, NOP14 and DNMT3B are involved in miR‐502‐5p–mediated inhibition of cell migration and proliferation in bladder cancer. Cell Proliferation. 53(2). e12751–e12751. 46 indexed citations
7.
Xu, Xin, Guanjun Zhang, Liujia He, & Yi Zhu. (2019). <p>Clinicopathological impacts of c-Met overexpression in bladder cancer: evidence from 1,336 cases</p>. OncoTargets and Therapy. Volume 12. 2695–2702. 8 indexed citations
8.
Xie, Haiyun, Jiangfeng Li, Yufan Ying, et al.. (2019). METTL3/YTHDF2 m <sup>6</sup>A Axis Promotes Tumorigenesis by Degrading SETD7 and KLF4 mRNAs in Bladder Cancer. SSRN Electronic Journal. 2 indexed citations
9.
Yan, Huaqing, Yufan Ying, Haiyun Xie, et al.. (2018). Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis. Cancer Management and Research. Volume 10. 3781–3791. 27 indexed citations
10.
He, Liujia, Jiangfeng Li, Xiao Wang, et al.. (2018). The dual role of N6‐methyladenosine modification of RNAs is involved in human cancers. Journal of Cellular and Molecular Medicine. 22(10). 4630–4639. 73 indexed citations
11.
Li, Jiangfeng, Shuai Meng, Mingjie Xu, et al.. (2017). Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels. Oncotarget. 9(3). 3752–3764. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026